218 related articles for article (PubMed ID: 23400686)
21. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of EGFR-PI3K-pAKT-mTOR-pS6 pathway in sinonasal squamous cell carcinomas.
Muñoz-Cordero MG; López F; García-Inclán C; López-Hernández A; Potes-Ares S; Fernández-Vañes L; Llorente JL; Hermsen M
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(1):16-24. PubMed ID: 29573781
[TBL] [Abstract][Full Text] [Related]
23. [Survival and prognostic analysis of 221 patients with advanced laryngeal squamous cell carcinoma treated by surgery].
Liu TR; Yang AK; Chen FJ; Zeng MS; Song M; Guo ZM; Chen WK; Ouyang D; Li QL; Chen YF; Zhang Q; Zeng ZY
Ai Zheng; 2009 Mar; 28(3):297-302. PubMed ID: 19619446
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.
Bussu F; Ranelletti FO; Gessi M; Graziani C; Lanza P; Lauriola L; Paludetti G; Almadori G
Laryngoscope; 2012 Aug; 122(8):1724-33. PubMed ID: 22549618
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of HAX-1 expression in laryngeal carcinoma.
You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
[TBL] [Abstract][Full Text] [Related]
27. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349
[TBL] [Abstract][Full Text] [Related]
28. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
29. Nodal metastases distribution in laryngeal cancer requiring total laryngectomy: Therapeutic implications for the N0 Neck.
Riviere D; Mancini J; Santini L; Loth Bouketala A; Giovanni A; Dessi P; Fakhry N
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S35-S38. PubMed ID: 30174259
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx.
Rafferty M; Helliwell TR; Husband DJ; Fenton J; Jones TM; Jones AS
Oral Oncol; 2008 Oct; 44(10):975-81. PubMed ID: 18329328
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
32. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
33. circRNA circ-CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR-646.
Zang Y; Li J; Wan B; Tai Y
J Cell Mol Med; 2020 Feb; 24(4):2423-2433. PubMed ID: 31951319
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
35. High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma.
Valente G; Giusti U; Kerim S; Gabriele P; Motta M; Ragona R; Navone R; Palestro G
Oncol Rep; 1999; 6(2):289-93. PubMed ID: 10022991
[TBL] [Abstract][Full Text] [Related]
36. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
39. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
Ji W; Guan C; Pan Z
Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse.
Almadori G; Cadoni G; Galli J; Ferrandina G; Scambia G; Exarchakos G; Paludetti G; Ottaviani F
Int J Cancer; 1999 Apr; 84(2):188-91. PubMed ID: 10096253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
